
Shareholders of UNI-BIO GROUP will deposit stocks into HSBC Hong Kong, with a storage market value of HKD 113 million

According to the latest information from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP deposited shares into HSBC Hong Kong, with a warehouse market value of HKD 113 million, accounting for 12.33%. Recently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokan Jian Gene Technology Co., Ltd. signed a strategic cooperation agreement with Sinovac Biotech Ltd., granting Sinovac exclusive commercialization rights for the innovative osteoporosis treatment drug Bogu Tai® in six countries (cooperation areas): Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico
According to the latest information from the Hong Kong Stock Exchange, on September 23, shareholders of UNI-BIO GROUP (00690) deposited shares into HSBC Hong Kong, with a warehouse market value of HKD 113 million, accounting for 12.33%.
Recently, UNI-BIO GROUP announced that its wholly-owned subsidiary Beijing Bokan Jian Gene Technology Co., Ltd. signed a strategic cooperation agreement with Sinovac Biotech Ltd., granting Sinovac exclusive commercialization rights for the innovative osteoporosis treatment drug Bogu Tai® in six countries (cooperation areas): Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico

